News | 03/09/2020 | Press Release, Award
ERC Starting Grant for new SyNergy member Prof. Dr. Lena Burbulla
Over 200,000 people in Germany suffer from Parkinson’s disease, a progressive movement disorder that is characterized by the specific loss of nerve cells that synthesize the neurotransmitter dopamine. The absence of dopamine results in an involuntary tremor and sluggish execution of voluntary movements. Starting from skin biopsy samples obtained from Parkinson patients, Lena Burbulla and her colleagues generated induced pluripotent stem cells and differentiated them into dopamine-producing nerve cells in culture. She went on to show that oxidative stress in patient neurons initiates a pathological cascade of events that primarily affects the functions of mitochondria (the “energy powerhouses” of the cell) and lysosomes (the waste disposal and recycling system of the cell). Over time, oxidized versions of dopamine accumulate further exacerbating this toxic cascade.